Dr. Amir T. Fathi is the Program Director and Director of Clinical Research at the Center for Leukemia at the Massachusetts General Hospital Cancer Center; he is also an Associate Professor in Medicine at Harvard Medical School. Dr. Fathi is a clinician-scientist with a deep interest in developing novel therapies for acute myeloid leukemia (AML).

Unfortunately, the outcomes for patients with AML continue to be poor despite incremental advances in treatment and supportive care over last 30 years. Although most patients respond to initial treatment, the majority eventually relapse and many succumb to their disease. Therefore, new and innovative approaches are desperately needed to significantly improve outcomes.

As faculty at the MGH Cancer Center and Harvard Medical School, he provides clinical care, supervises trainees, administers a busy clinic, and as the director of clinical research in leukemia, is the lead investigator on numerous clinical trials investigating novel treatments in acute leukemias. His other interests focus on developing translational projects to discover new targets for therapy. He has presented at national meetings of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH), spoken at national academic and educational meetings, and has served on national committees that establish guidelines for the management of acute and chronic leukemias. Dr. Fathi endeavors to provide outstanding clinical care, teaching and mentoring, while also conducting translational projects, retrospective research, and clinical trials, with the overarching goal improving the health and outcomes of patients with bone marrow malignancies.

Dr. Fathi is a graduate of Yale University, where he graduated summa cum laude with a Baccalaureate of Science in molecular, cellular, and developmental biology. He went on to receive his medical degree with Honors at the Yale School of Medicine.  He also has a Masters degree in Epidemiology from Harvard School of Public Health. He completed his residency training in internal medicine at Massachusetts General Hospital, and fellowships in both hematology and medical oncology at Johns Hopkins Hospital.